7B4-68650-82384
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 960 / CA
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Pfizer-BioNTech
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Burning sensation, Lacrimation increased, Loss of personal independence in daily activities, Periorbital swelling — Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Puffy right eye, severe burning sensation, eye watering excessively. Limited normal activity. I wear contact lenses, so this could be unrelated to the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to workFree text: Sore throat, headache, body aches, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Dose 2 — Pfizer-BioNTech
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: Asthenia, Chills, Diarrhoea, Headache, Nausea, Night sweats, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: After booster shot (so, my third shot) in early January 2022, ten days straight of severe debilitating headache, fever, chills, night sweats, nausea, and diarrhea. Tested multiple times during this time and was negative for COVID.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Puffy right eye, severe burning sensation, eye watering excessively. Limited normal activity. I wear contact lenses, so this could be unrelated to the vaccine.
Release 3 — day 14, dose 1
Symptoms: Sore throat, headache, body aches, fatigue
Release 11 — 12 months, dose 2
Symptoms: After booster shot (so, my third shot) in early January 2022, ten days straight of severe debilitating headache, fever, chills, night sweats, nausea, and diarrhea. Tested multiple times during this time and was negative for COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Burning sensation | ✓ | ✓ | ✓ |
| SRO | Lacrimation increased | ✓ | ✓ | ✓ |
| SRO | Loss of personal independence in daily activities | · | · | ✓ |
| SRO | Periorbital swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release